{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T08:02:50Z","timestamp":1774771370059,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00401-010-0791-x","type":"journal-article","created":{"date-parts":[[2010,12,29]],"date-time":"2010-12-29T00:51:57Z","timestamp":1293583917000},"page":"475-485","source":"Crossref","is-referenced-by-count":51,"title":["Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons"],"prefix":"10.1007","volume":"121","author":[{"given":"Manuel","family":"Garrido","sequence":"first","affiliation":[]},{"given":"Yuliya","family":"Tereshchenko","sequence":"additional","affiliation":[]},{"given":"Zinayida","family":"Zhevtsova","sequence":"additional","affiliation":[]},{"given":"Grit","family":"Taschenberger","sequence":"additional","affiliation":[]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[]},{"given":"Sebastian","family":"K\u00fcgler","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,12,30]]},"reference":[{"key":"791_CR1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/cbic.200300708","volume":"4","author":"TV Achenbach","year":"2003","unstructured":"Achenbach TV, Brunner B, Heermeier K (2003) Oligonucleotide-based knockdown technologies: antisense versus RNA interference. Chembiochem 4:928\u2013935","journal-title":"Chembiochem"},{"key":"791_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fernandez-Chacon R, Schl\u00fcter OM, S\u00fcdhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383\u2013396","journal-title":"Cell"},{"key":"791_CR3","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.freeradbiomed.2006.08.002","volume":"41","author":"SJ Chinta","year":"2006","unstructured":"Chinta SJ, Andersen JK (2006) Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson\u2019s disease. Free Radic Biol Med 41:1442\u20131448","journal-title":"Free Radic Biol Med"},{"key":"791_CR4","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1523\/JNEUROSCI.3885-07.2007","volume":"27","author":"SJ Chinta","year":"2007","unstructured":"Chinta SJ, Kumar MJ, Hsu M et al (2007) Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci 27:13997\u201314006","journal-title":"J Neurosci"},{"key":"791_CR5","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","volume":"29","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J Neurosci 29:3365\u20133373","journal-title":"J Neurosci"},{"key":"791_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tibs.2008.11.002","volume":"34","author":"I Dalle-Donne","year":"2009","unstructured":"Dalle-Donne I, Rossi R, Colombo G, Giustarini D, Milzani A (2009) Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci 34:85\u201396","journal-title":"Trends Biochem Sci"},{"key":"791_CR7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.2000.3930","volume":"279","author":"TP Dalton","year":"2000","unstructured":"Dalton TP, Dieter MZ, Yang Y, Shertzer HG, Nebert DW (2000) Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. Biochem Biophys Res Commun 279:324\u2013329","journal-title":"Biochem Biophys Res Commun"},{"key":"791_CR8","doi-asserted-by":"crossref","first-page":"38992","DOI":"10.1074\/jbc.M507065200","volume":"280","author":"JI Diaz-Hernandez","year":"2005","unstructured":"Diaz-Hernandez JI, Almeida A, Delgado-Esteban M, Fernandez E, Bolanos JP (2005) Knockdown of glutamate\u2013cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J Biol Chem 280:38992\u201339001","journal-title":"J Biol Chem"},{"key":"791_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","volume":"62","author":"R Dringen","year":"2000","unstructured":"Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649\u2013671","journal-title":"Prog Neurobiol"},{"key":"791_CR10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1471-4159.1996.67041375.x","volume":"67","author":"R Dringen","year":"1996","unstructured":"Dringen R, Hamprecht B (1996) Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J Neurochem 67:1375\u20131382","journal-title":"J Neurochem"},{"key":"791_CR11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1515\/BC.2000.153","volume":"381","author":"L Greenbaum","year":"2000","unstructured":"Greenbaum L, Rothmann C, Lavie R, Malik Z (2000) Green fluorescent protein photobleaching: a model for protein damage by endogenous and exogenous singlet oxygen. Biol Chem 381:1251\u20131258","journal-title":"Biol Chem"},{"key":"791_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.gde.2009.03.008","volume":"19","author":"J Hardy","year":"2009","unstructured":"Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson\u2019s syndromes: a critical review. Curr Opin Genet Dev 19:254\u2013265","journal-title":"Curr Opin Genet Dev"},{"key":"791_CR13","doi-asserted-by":"crossref","first-page":"W113","DOI":"10.1093\/nar\/gkh408","volume":"32","author":"A Henschel","year":"2004","unstructured":"Henschel A, Buchholz F, Habermann B (2004) DEQOR: a web-based tool for the design and quality control of siRNAs. Nucleic Acids Res 32:W113\u2013W120","journal-title":"Nucleic Acids Res"},{"key":"791_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"791_CR15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.1999.0730889.x","volume":"73","author":"R Janaky","year":"1999","unstructured":"Janaky R, Ogita K, Pasqualotto BA et al (1999) Glutathione and signal transduction in the mammalian CNS. J Neurochem 73:889\u2013902","journal-title":"J Neurochem"},{"key":"791_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","volume":"116","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1\u201316","journal-title":"Acta Neuropathol"},{"issue":"Suppl 2","key":"791_CR17","first-page":"S16","volume":"64","author":"P Jenner","year":"2008","unstructured":"Jenner P (2008) Functional models of Parkinson\u2019s disease: a valuable tool in the development of novel therapies. Ann Neurol 64(Suppl 2):S16\u2013S29","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"791_CR18","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","volume":"32","author":"P Jenner","year":"1992","unstructured":"Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson\u2019s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson\u2019s Disease Research Group. Ann Neurol 32(Suppl):S82\u2013S87","journal-title":"Ann Neurol"},{"key":"791_CR19","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.1073\/pnas.0706177104","volume":"104","author":"S Kowsky","year":"2007","unstructured":"Kowsky S, Poppelmeyer C, Kramer ER et al (2007) RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals. Proc Natl Acad Sci USA 104:20049\u201320054","journal-title":"Proc Natl Acad Sci USA"},{"key":"791_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0042-6822(03)00162-4","volume":"311","author":"S K\u00fcgler","year":"2003","unstructured":"K\u00fcgler S, Lingor P, Sch\u00f6ll U, Zolotukhin S, B\u00e4hr M (2003) Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology 311:89\u201395","journal-title":"Virology"},{"key":"791_CR21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253","journal-title":"J Neuropathol Exp Neurol"},{"key":"791_CR22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps. Apoptosis 14:478\u2013500","journal-title":"Apoptosis"},{"key":"791_CR23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbrc.2005.12.173","volume":"341","author":"I Malik","year":"2006","unstructured":"Malik I, Garrido M, B\u00e4hr M, K\u00fcgler S, Michel U (2006) Comparison of test systems for RNA interference. Biochem Biophys Res Commun 341:245\u2013253","journal-title":"Biochem Biophys Res Commun"},{"key":"791_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymthe.2004.11.014","volume":"11","author":"JM Malik","year":"2005","unstructured":"Malik JM, Shevtsova Z, B\u00e4hr M, K\u00fcgler S (2005) Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol Ther 11:373\u2013381","journal-title":"Mol Ther"},{"key":"791_CR25","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1096\/fj.08-125443","volume":"23","author":"HL Martin","year":"2009","unstructured":"Martin HL, Teismann P (2009) Glutathione\u2014a review on its role and significance in Parkinson\u2019s disease. FASEB J 23:3263\u20133272","journal-title":"FASEB J"},{"key":"791_CR26","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1046\/j.1471-4159.2000.0742305.x","volume":"74","author":"K Nakamura","year":"2000","unstructured":"Nakamura K, Wright DA, Wiatr T et al (2000) Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin. J Neurochem 74:2305\u20132314","journal-title":"J Neurochem"},{"key":"791_CR27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","volume":"104","author":"RK Pearce","year":"1997","unstructured":"Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson\u2019s disease. J Neural Transm 104:661\u2013677","journal-title":"J Neural Transm"},{"key":"791_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"TL Perry","year":"1982","unstructured":"Perry TL, Godin DV, Hansen S (1982) Parkinson\u2019s disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33:305\u2013310","journal-title":"Neurosci Lett"},{"key":"791_CR29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","volume":"67","author":"TL Perry","year":"1986","unstructured":"Perry TL, Yong VW (1986) Idiopathic Parkinson\u2019s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67:269\u2013274","journal-title":"Neurosci Lett"},{"key":"791_CR30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch WD et al (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515\u2013520","journal-title":"J Neurochem"},{"key":"791_CR31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","volume":"50","author":"RK Schwarting","year":"1996","unstructured":"Schwarting RK, Huston JP (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50:275\u2013331","journal-title":"Prog Neurobiol"},{"key":"791_CR32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/sj.gt.3302822","volume":"13","author":"Z Shevtsova","year":"2006","unstructured":"Shevtsova Z, Malik I, Garrido M, Sch\u00f6ll U, B\u00e4hr M, K\u00fcgler S (2006) Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons. Gene Ther 13:1569\u20131578","journal-title":"Gene Ther"},{"key":"791_CR33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ et al (1994) Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348\u2013355","journal-title":"Ann Neurol"},{"key":"791_CR34","doi-asserted-by":"crossref","unstructured":"Thomas B, Beal MF (2007) Parkinson\u2019s disease. Hum Mol Genet 16(Spec No. 2):R183\u2013R194","DOI":"10.1093\/hmg\/ddm159"},{"key":"791_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01271295","volume":"104","author":"S Toffa","year":"1997","unstructured":"Toffa S, Kunikowska GM, Zeng BY, Jenner P, Marsden CD (1997) Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J Neural Transm 104:67\u201375","journal-title":"J Neural Transm"},{"key":"791_CR36","doi-asserted-by":"crossref","first-page":"47763","DOI":"10.1074\/jbc.C100415200","volume":"276","author":"J Wang","year":"2001","unstructured":"Wang J, Boja ES, Tan W et al (2001) Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276:47763\u201347766","journal-title":"J Biol Chem"},{"key":"791_CR37","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1021\/bi000781g","volume":"39","author":"NE Ward","year":"2000","unstructured":"Ward NE, Stewart JR, Ioannides CG, O\u2019Brian CA (2000) Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry 39:10319\u201310329","journal-title":"Biochemistry"},{"key":"791_CR38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","volume":"62","author":"GD Zeevalk","year":"2008","unstructured":"Zeevalk GD, Razmpour R, Bernard LP (2008) Glutathione and Parkinson\u2019s disease: is this the elephant in the room? Biomed Pharmacother 62:236\u2013249","journal-title":"Biomed Pharmacother"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00401-010-0791-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T06:37:09Z","timestamp":1559889429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-010-0791-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,30]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1007\/s00401-010-0791-x","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,30]]}}}